Aboluwarin  Abimbola (@aboluwarinbimbo) 's Twitter Profile
Aboluwarin Abimbola

@aboluwarinbimbo

ID: 2207881739

calendar_today04-12-2013 20:40:23

487 Tweet

176 Followers

484 Following

BCRN (@clotrecoverynet) 's Twitter Profile Photo

If you're here, chances are your life as been impacted by a #BloodClot. Here is what I wish I knew right after I was diagnosed with DVT and PE. Read more: bloodclotrecovery.net/you-survived-a…

If you're here, chances are your life as been impacted by a #BloodClot. Here is what I wish I knew right after I was diagnosed with DVT and PE. Read more: bloodclotrecovery.net/you-survived-a…
Ferran Nadeu (@ferrannadeu) 's Twitter Profile Photo

Happy to see our ‘all-CLL panel’ published in HemaSphere Journal (IF = 14.6)! Molecular characterization of CLL made simple!! Molecular = immunoglobulins + gene mutations + copy number alterations Here below the link and a short summary 🧵 journals.lww.com/hemasphere/ful…

Talha Badar (@talhabadarmd) 's Twitter Profile Photo

Weekend review 📖 🧵 1/5 The story of Luspatercept! Luspatercept, TGF-B fusion trap protein, neutralizes TGF-B and restore effective erythropoiesis.

Weekend review 📖 🧵 1/5

The story of Luspatercept! 

Luspatercept, TGF-B fusion trap protein, neutralizes TGF-B and  restore effective erythropoiesis.
Thulasi Raman (@thulas31081987) 's Twitter Profile Photo

Case discussion: A 57 yr Male presented with Hb of 5.9 g/dl, Total count of 274800 and platelet count of 71000. Peripheral smear microphotograph attached. Likely Diagnosis ?

Case discussion: 
A 57 yr Male presented with Hb of 5.9 g/dl, Total count of 274800 and platelet count of 71000. Peripheral smear microphotograph attached. 
Likely Diagnosis ?
Nishant Rajendra Tiwari (@nischistocyte) 's Twitter Profile Photo

Educational thread on complications of blood transfusion. Not medical advice. Open to feedback and corrections! The incidence rates are as reported in the USA. #MedX #Hematology #Transfusion #Bloodbank #InternalMedicine #MedEd

Educational thread on complications of blood transfusion. Not medical advice. Open to feedback and corrections! The incidence rates are as reported in the USA.
#MedX #Hematology #Transfusion #Bloodbank #InternalMedicine #MedEd
Uriel Suárez (@usuarezmd) 's Twitter Profile Photo

2008 ⁦@BloodJournal⁩ Very useful ☝🏻 Flow cytometric immunophenotyping for hematologic neoplasms | Blood | American Society of Hematology ashpublications.org/blood/article/…

Daniela Hermelin, MD (@hermelinmd) 's Twitter Profile Photo

👏🏼Wow! You are good. With a megaloblastic anemia, consider Vit B12/folate deficiency. Severe deficiency will also cause a thrombocytopenia and will begin to affect the bone marrow leading to other red blood abnormalities. 👆🏼This is how my day started and a simple lab test

👏🏼Wow!  You are good.  
With a megaloblastic anemia, consider Vit B12/folate deficiency.  

Severe deficiency will also cause a thrombocytopenia and will begin to affect the bone marrow leading to other red blood abnormalities. 

👆🏼This is how my day started and a simple lab test
Mushtaq Bilal, PhD (@mushtaqbilalphd) 's Twitter Profile Photo

How to use ChatGPT smartly to supercharge your academic writing (complete prompts included): [This process involves no cheating and no plagiarism.]

William Aird (@williamaird4) 's Twitter Profile Photo

1/9 CASE I was referred a case of iron deficiency last week with the lowest MCV I have ever seen in a patient (MCV 48 fL, baseline 77 with normal Hb electrophoresis suggesting concomitant alpha thalassemia trait). A) What are the implications for oxygen delivery?

1/9

CASE

I was referred a case of iron deficiency last week with the lowest MCV I have ever seen in a patient (MCV 48 fL, baseline 77 with normal Hb electrophoresis suggesting concomitant alpha thalassemia trait). 

A) What are the implications for oxygen delivery?
PharmaFactz (@pharmafactz) 's Twitter Profile Photo

🔴 DMARD TARGETS / MECHANISM. 👉 abatacept - T-cell costimulatory signal inhibitor 👉 adalimumab - TNF inhibitor 👉 anakinra - IL-1 receptor antagonist 👉 apremilast - PDE4 inhibitor 👉 azathioprine - purine synthesis inhibitor 👉 baricitinib - JAK1 and JAK2 inhibitor 👉

Sickle Cell Society (@sicklecelluk) 's Twitter Profile Photo

We are disappointed by yesterday’s decision of the Medicines and Healthcare products Regulatory Agency (MHRA) to withdraw the marketing authorisation for Crizanlizumab (Adakveo), which was a new and promising treatment for people living with Sickle Cell. sicklecellsociety.org/crizanlizumab-…

We are disappointed by yesterday’s decision of the Medicines and Healthcare products Regulatory Agency (MHRA) to withdraw the marketing authorisation for Crizanlizumab (Adakveo), which was a new and promising treatment for people living with Sickle Cell.  
sicklecellsociety.org/crizanlizumab-…
Transfusion Library (@transfusionlib) 's Twitter Profile Photo

New from #Transfusion Evidence Library: Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies by Buckstein et al. transfusionevidencelibrary.com/alerts/article…

New from #Transfusion Evidence Library:

Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies
by Buckstein et al.
transfusionevidencelibrary.com/alerts/article…
Marc Braunstein, MD, PhD, FACP (@docbraunstein) 's Twitter Profile Photo

How I manage bone modifying agents (BMAs) in #myeloma to avoid jaw osteonecrosis: #mmsm - Obtain dental eval before starting BMAs - If pending invasive dental procedure, advise holding BMAs 2-3 months before and after - Dental exams every 6 months Ref: mdpi.com/2072-6694/13/1…

How I manage bone modifying agents (BMAs) in #myeloma to avoid jaw osteonecrosis: #mmsm 
- Obtain dental eval before starting BMAs
- If pending invasive dental procedure, advise holding BMAs  2-3 months before and after
- Dental exams every 6 months
Ref: mdpi.com/2072-6694/13/1…